251 / 264
Selected Section Materials by Author
I - 6
Rettig EM, D'Souza G, Thompson CB, et al. Health-related quality of life before and after head and neck
squamous cell carcinoma: analysis of the Surveillance, Epidemiology, and End Results-Medicare Health
Outcomes Survey linkage.
Cancer
. 2016; 122(12):1861-1870. EBM level 4
Ryu IS, Roh JL, Kim JS, et al. Impact of (18)F-FDG PET/CT staging on management and prognostic
stratification in head and neck squamous cell carcinoma: a prospective observational study.
Eur J Cancer
.
2016; 63:88-96. EBM level 2
Schilling C, Stoeckli SJ, Haerle SK, et al. Sentinel European Node Trial (SENT): 3-year results of sentinel node
biopsy in oral cancer.
Eur J Cancer
. 2015; 51(18):2777-2784. EBM level 2
Sethugavalar B, Teo MT, Buchan C, et al. Impact of prophylactic gastrostomy or reactive NG tube upon
patient-reported long term swallow function following chemoradiotherapy for oropharyngeal carcinoma: a
matched pair analysis.
Oral Oncol
. 2016; 59:80-85. EBM level 3
Taghipour M, Sheikhbahaei S, Marashdeh W, et al. Use of 18F-fludeoxyglucose-positron emission
tomography/computed tomography for patient management and outcome in oropharyngeal squamous cell
carcinoma: a review.
JAMA Otolaryngol Head Neck Surg
. 2016; 142(1):79-85. EBM level 3
Ward MC, Adelstein DJ, Bhateja P, et al. Severe late dysphagia and cause of death after concurrent
chemoradiation for larynx cancer in patients eligible for RTOG 91-11.
Oral Oncol
. 2016; 57:21-26. EBM
level 3
Yimaer W, Abudouyimu A, Tian Y, et al. Efficacy and safety of vascular endothelial growth factor receptor
tyrosine kinase inhibitors in the treatment of advanced thyroid cancer: a meta-analysis of randomized controlled
trials.
Onco Targets Ther
. 2016; 9:1167-1173. EBM level 1
Section 8: Otology and Neurotology
Ahsan SF, Seidman M, Yaremchuk K. What is the best imaging modality in evaluating patients with unilateral
pulsatile tinnitus?
Laryngoscope
. 2015; 125(2):284-285. EBM level 5
Briggs R, Van Hasselt A, Luntz M, et al. Clinical performance of a new magnetic bone conduction hearing
implant system: results from a prospective, multicenter, clinical investigation.
Otol Neurotol
. 2015; 36(5):834-
841. EBM level 2b
Cannon RB, Thomson RS, Shelton C, Gurgel RK. Long-term outcomes after middle fossa approach for
traumatic facial nerve paralysis.
Otol Neurotol
. 2016; 37(6):799-804. EBM level 4
Chang TP, Lin YW, Sung PY, et al. Benign paroxysmal positional vertigo after dental procedures: a
population-based case-control study.
PLOS One
. 2016; 11(4):e0153092. EBM level 3
Crowson MG, Patki A, Tucci DL. A systematic review of diuretics in the medical management of Ménière’s
disease.
Otolaryngol Head Neck Surg
. 2016; 154(5);824-834. EBM level 3
Crowson MG, Ramprasad VH, Chapurin N, et al. Cost analysis and outcomes of a second-look tympanoplasty-
mastoidectomy strategy for cholesteatoma.
Laryngoscope
. 2016; 126(11):2574-2579. EBM level 4
Dieterich M, Obermann M, Celebisoy N. Vestibular migraine: the most frequent entity of episodic vertigo.
J
Neurol
. 2016; 263 Suppl 1:S82-S89. EBM level 5